FDA inspection
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site): FDA inspection ending Oct 14, 2010
FDA inspection 697592 · No Action Indicated (NAI) · Hanzhong
Key facts
| Inspection ID | 697592 |
|---|---|
| Firm | Shaanxi Hanjiang Pharmaceutical Group Co., Ltd (Gaoxin site) |
| FEI number | 3003011617 |
| Address | Hanzhong Hi-tech Industries Development Zone, 3 Lianhua Road |
| City | Hanzhong |
| Country | China |
| Fiscal year | 2011 |
| Inspection end date | Oct 14, 2010 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data